CIN Clinical Trial
— CINOECTOfficial title:
To Compare Intravenous and Oral Hydration of the Prevention for Contrast-induced Nephropathy in Elderly Patients Undergoing Intravenous Contrast-enhanced Computed Tomography: A Multi-center Randomized Control Trail
To Compare Intravenous and Oral Hydration of the Prevention for Contrast-induced Nephropathy in Elderly Patients Undergoing Intravenous Contrast-enhanced Computed Tomography.
Status | Recruiting |
Enrollment | 1368 |
Est. completion date | October 2021 |
Est. primary completion date | June 30, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 65 Years and older |
Eligibility |
Inclusion Criteria: - Age>21 - informed consent - Undergoing Intravenous Contrast-enhanced Computed Tomography Exclusion Criteria: - CT enhancement was not performed; - Dialysis treatment of patients with end-stage renal failure or heart, kidney transplantation; - Exposure to radioactive contrast medium within 48 hours prior to or within 72 hours of examination; - Acute decompensated heart failure; - Allergic to radioactive contrast agent; - Be subjected to life - threatening trauma; - Severe infection; - Surgery was performed within 2 days of CT examination. - Combined with multiple myeloma, urinary obstruction, aortic dissection - Can cause acute kidney injury disease; - Use of aminoglycosides and other nephrotoxic drugs 2 weeks before. |
Country | Name | City | State |
---|---|---|---|
China | Guangdong provincial people's hospital | Guanzhou | Guangdong |
Lead Sponsor | Collaborator |
---|---|
Yu Danqing |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | CIN | Compared with before examination, the increase of serum creatinine conforms to the diagnostic criteria of contrast induced nephropathy. | 72hours |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00339989 -
Cervical Cancer Early Endpoints and Determinants
|
||
Active, not recruiting |
NCT05580341 -
Phase III Study Comparing the Immunogenicity of 9-valent HPV Recombinant Vaccine and Gardasil-9
|
Phase 3 | |
Completed |
NCT01766284 -
Study of the Diagnostic Efficacy of "Real Time" Niris 1300e Optical Coherence Tomography (OCT) Imaging System in the Management of Pre-invasive and Invasive Neoplasia of the Uterine Cervix
|
N/A | |
Completed |
NCT02363244 -
Pap and HPVDNA Before and After Acetic Acid
|
||
Recruiting |
NCT02116920 -
HPV E6/E7 mRNA Versus HPV DNA as Triage for Cervical Cancer Screening
|
N/A | |
Enrolling by invitation |
NCT01836588 -
New Gentle Biopsy Method of Cervix Lesions Using Superficial Curettage/Protocol ID: CX-CUR
|
N/A | |
Completed |
NCT00289029 -
A Study of Two Iodinated Contrast Agents in Renally Impaired Patients Undergoing Cardiac Angiography
|
Phase 4 | |
Recruiting |
NCT06261879 -
Non-invasive Biomarker Discovery for Pre-cervical or/and Cervical Cancer--ACTN4 and Other Biomarkers in Menstrual Blood
|
N/A | |
Completed |
NCT03239223 -
Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection
|
Phase 1 | |
Completed |
NCT03791606 -
Risk Factors,PREvention and OutComes for CI-AKI in PatientS undErgoing PCI at Intensive Care Unit(PRECISE-ICU)
|
||
Completed |
NCT04809727 -
Histopathological Findings in Symptomatizing Patients After Supracervical Hysterectomy
|
N/A |